top of page
woman-holding-human-heart-model-cardiovascular-di-2023-11-27-04-58-58-utc_edited.jpg

Atrial Fibrillation

Welcome to D&H National Research Centers, where we invite you to be a part of groundbreaking research that aims to improve the lives of individuals living with Atrial Fibrillation and get up $950 Compensation.

Atrial fibrillation (AF) is an irregular and often very rapid heart rhythm. AF can lead to blood clots in the heart. The condition also increases the risk of stroke, heart failure and other heart-related complications. Episodes of atrial fibrillation may come and go, or they may be persistent. AF itself usually isn't life-threatening. But it's a serious medical condition that needs proper treatment to prevent stroke.

Atrial happy old couple_edited.jpg

D&H National Research Centers is currently conducting a medical trial on Atrial fibrillation. As a prominent leader in clinical research in Florida, we are committed to advancing medical knowledge and patient care.

Inclusion Criteria:

 

If you want to participate in this study, you must meet the following criteria:

  • Male or female subjects aged 65-74 and CHA2DS2VASc ≥5 OR age ≥75 and
    CHA2DS2VASc ≥4

  • Diagnosed AF or atrial flutter (documented on an electrocardiogram or monitor recording).

  • At least 1 of the following:

  1. Severe kidney disease.

  2.  -Planned daily use of aspirin, a P2Y12 inhibitor, or other
    antiplatelet agent for the duration of the trial

  3. History of bleeding from a critical area or organ or major gastrointestinal bleeding

 

Exclusion Criteria:

 

You are not eligible for participation in this study if:

 

  • AF due to an ongoing acute reversible cause (e.g., cardiac surgery, pulmonary embolism (PE), untreated hyperthyroidism,
    alcohol use).

  • Patients who received warfarin, dabigatran, rivaroxaban, apixaban, or edoxaban within 60 days prior to randomization.

  • Any stroke within 14 days before randomization or TIA within 3
    days before randomization. 

  • Mechanical heart valve or valve disease that is expected to require mechanical valve replacement intervention during the
    course of the study.

  • Patients on dialysis at screening or who are planned to start dialysis within 6 months

calm-man-exercising-with-closed-eyes-outside-2023-11-27-05-01-53-utc_edited_edited.png

Are you or a loved one suffering from Atrial Fibrillation (AF)? If so, you may be interested in participating in our clinical trial.  In D&H National Research Centers we are conducting research on new treatments for AF that could potentially improve your quality of life and provide hope for a brighter future.

Our trial is designed to:

  • Access to innovative treatments: By participating in our clinical trial, you will have the opportunity to receive cutting-edge treatments that could potentially improve your AF symptoms and overall quality of life.

  • Expert medical care: The D&H National Research Centers team of healthcare professionals and researchers will closely monitor your progress throughout the trial, ensuring that you receive the highest standard of care. and support.

  • Contribution to medical research: By participating in our clinical trial, you will be contributing to the advancement of medical science and helping to improve the lives of future AF patients.

  • Compensation: As a token of appreciation for your participation, you may be eligible for compensation for your time and travel expenses up $900.

Diseño sin título_edited.png
cropped-view-of-adopted-child-and-parent-holding-r-2023-11-27-04-50-45-utc_edited.jpg

D&H National Research Centers is a leading medical trial center located in Florida. 

If you are interested in joining our Atrial Fibrillation medical trial or have questions about the study, please don't hesitate to reach out to us. We are here to provide you with all the information and support you need, please fill the form or contact us by phone: (786) 375-6210

Join the study

bottom of page